Latest AI and machine learning research in prostate cancer for healthcare professionals.
The efficient and unbiased isolation of small extracellular vesicles (sEVs) from complex biological fluids remains a major obstacle for clinical diagnostics. Here, we report a bioinspired microfluidic chip that integrates a three-dimensional high-curvature TiO2 nano-interface (3D Hic-TiO2) with a biotin-modified artificial insertion peptide (BAIP) modification for rapid enrichment of sEV. Bowl-sha...
OBJECTIVE: To assess the diagnostic performance of semen RNA-based biomarkers for detecting prostate cancer and differentiating cancer grade groups. METHODS: In a multi-center prospective study, semen samples were collected from men prior to undergoing prostate biopsy. RNA was extracted and sequenced to generate exome-wide gene expression profiles. Differentially expressed genes were selected and ...
Patent ductus arteriosus (PDA) is a common congenital heart defect that requires timely and accurate detection to guide clinical management. Although ...
BACKGROUND: Micro-ultrasound (micro-US) is a clinically available novel high-resolution imaging technology for guiding prostate biopsies. However, cli...
BACKGROUND: Machine Learning (ML) models have achieved outstanding performance in predicting post-surgical survival. However, the "black-box" nature o...
The diagnosis of prostate cancer (PCa) is limited by the low specificity of prostate-specific antigen (PSA) testing, which contributes to overdiagnosi...
Steady state visual evoked potential (SSVEP)-based brain-computer interfaces have been widely studied for their fast response speeds and high informat...
In the event of a severe nuclear accident at a coastal nuclear power plant, the rapid and accurate assessment of radionuclide dispersion in surroundin...
BACKGROUND: Recognized worldwide as a major health threat and Sustainable Development Goal priority, breast cancer places an especially heavy clinical...
BACKGROUND: Prostate‑specific antigen (PSA) screening involves complex trade‑offs between early detection and the risks of overdiagnosis. For older ad...
Personalized treatment in psoriatic arthritis (PsA) remains challenging, particularly in guiding dose escalation decisions. We applied a causal machin...
The non-invasive diagnosis and risk stratification of prostate cancer (PCa) remain clinically challenging due to the limited specificity of prostate-s...
BACKGROUND: Resective epilepsy surgery has been proven to reduce the number of seizures and improve quality of life in patients with drug-resistant ep...
The Extracellular Vesicles Gene-based Prostate Score (EGPS), powered by DeepSeek, is an artificial intelligence (AI) diagnostic tool that enhances the...
PURPOSE OF REVIEW: Biochemical recurrence (BCR) after radical prostatectomy occurs in up to one-third of patients and increases the risk of metastasis...
OBJECTIVE: We evaluated a commercial artificial intelligence (AI) system as a concurrent decision-support tool for clinically significant prostate can...
INTRODUCTION: Prostate-specific antigen (PSA) alone is insufficient for the diagnosis of prostate cancer (PCa), particularly within the gray zone rang...
Prostate cancer (PCa) remains a major global health burden, with incidence rising as populations age. The molecular, histological, and patient-specifi...
Accurate early detection of clinically significant prostate cancer is crucial for improving patient outcomes. However, traditional diagnostic methods ...
It is imperative to identify patients with prostate cancer (PCa) who will not benefit from androgen receptor signaling inhibitors and to improve their...